Dr. Patterson’s paper being published is a big deal. Its big for the doctors to know what effect Leronlimab is having on Covid from our first study and how the lab results correspond with the effective anecdotal results. The viral load went to zero after the second dose. No other drug has results like this.

As for seeing a result in the stock price from the journal paper being printed. It’s up to Cytodyn to blow this up with press releases that allow the public to see and follow our trial. The press will help to get the word out but we need national exposure and this is important enough to get the main stream media’s attention. Then with what we had as an interim look and it showed very promising to continue the trial and meeting our main end point. That it’s quite possible that our next interim look will stop the trial and seek a EUA.

I am not the person to push the media or articles needed. We should have a media group hired to promote us. You might of heard of them? I hear so little from them I can’t keep straight which one we are with anymore. Not a good sign huh? Cytodyn has fired a few media companies that promote us. Hopefully we find the right company to promote our excellent results that we all know about but nobody else does. Someday we will have our own media person to do this. When we become a Pharmaceutical company with revenue. We are getting closer. It’s just a matter of a little more time.